Topics
News
CME/CE
Editorial Advisory Board
Partners
Subscribe
Sponsored Content
>Sponsored Content
OX40-Ligand: A Conductor of the Atopic Dermatitis Inflammatory Symphony?
April W. Armstrong, MD, MPH, Professor and Chief of Dermatology, University of California, Los Angeles;Kassim Rahawi, PharmD, Sanofi, Cambridge, USA;Wendell Valdecantos, MD, Sanofi, Cambridge, USA;Stella Kyaw-Soe, PharmD, MBA, Sanofi, Cambridge, USA
October 22nd 2024Given the complexity of the underlying inflammation in patients with AD, an increased understanding of the OX40L pathway can improve our understanding of AD pathogenesis.
